SAN DIEGO (AP) — SAN DIEGO (AP) — Cidara Therapeutics Inc. (CDTX) on Thursday reported a loss of $83.2 million in its third quarter.
On a per-share basis, the San Diego-based company said it had a loss of $3.10. Losses, adjusted for research and development costs, were $1.43 per share.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.19 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CDTX at https://www.zacks.com/ap/CDTX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
